Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer

Prostate Cancer

(2017) James Mohler et al.   Journal of the National Comprehensive Cancer Network

Variability in Diagnostic Opinion Among Pathologists for Single Small Atypical Foci in Prostate Biopsies

(2010) Theodorus H. Van der Kwast et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Prostate cancer genes associated with TMPRSS2–ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts

(2010) B G Barwick et al.   BRITISH JOURNAL OF CANCER

Predictive models in external beam radiotherapy for clinically localized prostate cancer

(2010) Mack Roach et al.   CANCER

Sequence Variant Discovery in DNA Repair Genes from Radiosensitive and Radiotolerant Prostate Brachytherapy Patients

(2009) T. J. Pugh et al.   CLINICAL CANCER RESEARCH

Oncogenic gene fusions in epithelial carcinomas

(2009) John R Prensner et al.   CURRENT OPINION IN GENETICS & DEVELOPMENT

Synthetic lethal targeting ofPTENmutant cells with PARP inhibitors

(2009) Ana M. Mendes-Pereira et al.   EMBO Molecular Medicine

Three-Dimensional Prostate Mapping Biopsy Has a Potentially Significant Impact on Prostate Cancer Management

(2009) Gary Onik et al.   JOURNAL OF CLINICAL ONCOLOGY

High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer

(2009) Adrian S. Ishkanian et al.   PROSTATE

Selenium status of the Swiss population: Assessment and change over a decade

(2008) Judith Burri et al.   JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY

Nutlin-3 radiosensitizes hypoxic prostate cancer cells independent of p53

(2008) S. Supiot et al.   MOLECULAR CANCER THERAPEUTICS

PRIMA-1met radiosensitizes prostate cancer cells independent of their MTp53-status

(2008) Stéphane Supiot et al.   RADIOTHERAPY AND ONCOLOGY